However, this cross-sectional study is limited in establishing causality
Participation in a trial could provide access to the therapy under research conditions
[1] [2] GLP-1 medications work through several complementary mechanisms: Enhancing insulin secretion : They stimulate the pancreas to release insulin when blood glucose levels are elevated, helping to lower blood sugar in a glucose-dependent manner Suppressing glucagon release : They reduce the secretion of glucagon, a hormone that raises blood glucose, thereby preventing excessive glucose production by the liver Slowing gastric emptying : They delay the rate at which food leaves the stomach, leading to more gradual glucose absorption and increased feelings of fullness Reducing appetite : They act on areas of the brain involved in appetite regulation, helping to decrease food intake [2] [22] Commonly prescribed GLP-1 receptor agonists in the UK include semaglutide (Ozempic for diabetes, Wegovy for weight management, Rybelsus as an oral formulation), dulaglutide (Trulicity), liraglutide (Victoza for diabetes, Saxenda for weight management), and exenatide (Byetta, Bydureon)
Patients with active liver disease, severe renal impairment, or unstable cardiovascular conditions require extra caution
Our care team helps with scheduling, intake, insurance steps, and follow-up so you are supported between visits
